Buettner, F. | Search bioRxiv

bioRxiv2017

Multi-Omics factor analysis disentangles heterogeneity in blood cancer

Multi-omic studies promise the improved characterization of biological processes across molecular layers. However, methods for the unsupervised integration of the resulting heterogeneous datasets are lacking. We present Multi-Omics Factor Analysis (MOFA), a computational method for discovering the principal sources of variation in multi-omic datasets. MOFA infers a set of (hidden) factors that capture biological and technical sources of variability. It disentangles axes of heterogeneity that are shared across multiple modalities and those specific to individual data modalities. The learnt factors enable a variety of downstream analyses, including identification of sample subgroups, data imputation, and the detection of outlier samples. We applied MOFA to a cohort of 200 patient samples of chronic lymphocytic leukaemia, profiled for somatic mutations, RNA expression, DNA methylation and ex-vivo drug responses. MOFA identified major dimensions of disease heterogeneity, including immunoglobulin heavy chain variable region status, trisomy of chromosome 12 and previously underappreciated drivers, such as response to oxidative stress. In a second application, we used MOFA to analyse single-cell multiomics data, identifying coordinated transcriptional and epigenetic changes along cell differentiation.

bioinformatics↗

bioRxiv2016

Scalable latent-factor models applied to single-cell RNA-seq data separate biological drivers from confounding effects

Single-cell RNA-sequencing (scRNA-seq) allows heterogeneity in gene expression levels to be studied in large populations of cells. Such heterogeneity can arise from both technical and biological factors, thus making decomposing sources of variation extremely difficult. We here describe a computationally efficient model that uses prior pathway annotation to guide inference of the biological drivers underpinning the heterogeneity. Moreover, we jointly update and improve gene set annotation and infer factors explaining variability that fall outside the existing annotation. We validate our method using simulations, which demonstrate both its accuracy and its ability to scale to large datasets with up to 100,000 cells. Moreover, through applications to real data we show that our model can robustly decompose scRNA-seq datasets into interpretable components and facilitate the identification of novel sub-populations.

bioinformatics↗